[Paclitaxel (taxol)--a cytostatic drug with a new type of mechanism of action].
Schalhorn
B
B
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use*; D002470:Cell Survival / Q000187:drug effects; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008870:Microtubules / Q000187:drug effects; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017239:Paclitaxel / Q000009:adverse effects / Q000627:therapeutic use*; D015996:Survival Rate
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel
Paclitaxel (Taxol)--ein Zytostatikum mit neuartigem Wirkmechanismus.